Fibrinogen and other coronary risk factors

Metabolism: Clinical and Experimental

Volumn 54, Issue 2, 2005, Pages 165-170

  Von Eyben, Finn Edler ^a,f   Mouritsen, Ejvind Aae ^a   Holm, Jan ^a   Montvilas, Paulius ^a   Dimcevski, Georg ^a   Rasmussen, Inge Helleberg ^b   Kristensen, Lisbeth Langholz ^c   Suciu, Gabriel ^d   Von Eyben, Riel ^e  

^a HERNING HOSPITAL   (Denmark)

^b Tarm Hospital   (Denmark)

^c Varde Hospital   (Denmark)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Center of Tobacco Control Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CAPILLARY BLOOD; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; SOCIAL CLASS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FIBRINOGEN; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; TRIGLYCERIDES;

EID: 12944326870     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.08.008     Document Type: Article

References (41)

1. G. De Backer, E. Ambrosioni, and K. Borch Johnsen European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Eur. J. Cardiovasc. Prev. Rehabil. 10 2003 S1 S78
2. P.Y. Scarabin, D. Arveiler, and P. Amoyel Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study Atherosclerosis 266 2003 103 109
3. F.E. von Eyben, E. Mouritsen, and J. Holm Smoking, low density lipoprotein cholesterol, fibrinogen, and acute myocardial infarction before 41 years of age: a Danish case-control study J. Cardiovasc. Risk 9 2002 171 178
4. L. Moller, and T.S. Kristensen Plasma fibrinogen and ischemic heart disease risk factors Arterioscler. Thromb. Vasc. Biol. 11 1991 344 350
5. A.R. Folsom, K.K. Wu, and C.E. Davis Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors Atherosclerosis 91 1991 191 205
6. K. Krobot, H.W. Henze, P. Cremer, E. Eberle, and U. Keil Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990 Arterioscler. Thromb. Vasc. Biol. 12 1992 780 788
7. J.W. Yarnell, P.M. Sweetman, A. Rumley, and G.D. Lowe Life style and hemostatic risk factors for ischemic heart disease. The Caerphilly Study Arterioscler. Thromb. Vasc. Biol. 20 2000 271 279
8. M. Eliasson, P.E. Evrin, and D. Lundblad Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the North Sweden Monica Study J. Clin. Epidemiol. 47 1994 513 524
9. E. Brunner, G.D. Smith, and M. Marmot Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen Lancet 347 1996 1008 1013
10. S. Sato, H. Iso, and Y. Naito Plasma fibrinogen and its correlates in urban Japanese men Int. J. Epidemiol. 25 1996 521 527
11. P.Y. Scarabin, M.F. Aillaud, and P. Amouyel Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction Thromb. Haemost. 80 1998 749 756
12. M. Eliasson, K. Asplund, P.-E. Evrin, B. Lindahl, and D. Lundblad Hyperinsulinemia predicts low tissue plasminogen activator inhibitor activity in a healthy population: the Northern Sweden MONICA Study Metabolism 43 1994 1579 1586
13. M. Eliasson, M.E. Roder, and B. Dinesen Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects Diabetes Care 20 1997 1252 1255
14. F.E. von Eyben, E. Mouritsen, and J. Holm Intra-abdominal obesity and metabolic risk factors: a study of young adults Int. J. Obes. Relat. Metab. Disord. 27 2003 941 949
15. K. Svalastoga Prestige, class, and mobility 1959 Munksgaard Copenhagen
16. E.J. Hansen Social groups in Denmark Socialgrupper i Danmark 1984 Institute of Social Science Copenhagen
17. W.T. Friedewall, G.R. Warwick, and N.B. Johnson Estimation of serum low density lipoprotein cholesterol without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
18. J. Jeppesen, H.O. Hein, and P. Suadicani Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study Circulation 97 1998 1029 1036
19. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet. Med. 15 1998 539 553
20. D.G. Altman Practical statistics for medical research 1991 Chapman & Hall London
21. F. von Eyben, and R. von Eyben Smoking and other major coronary risk factors and acute myocardial infarction before 41 years of age-two Danish case control studies Scand. Cardiovasc. J. 35 2001 25 29
22. J.S. Pankow, A.R. Folsom, and M.A. Province Family history of coronary heart disease and hemostatic variables in middle-aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Research Group Thromb. Haemost. 77 1997 87 93
23. M. de Lange, H. Snieder, R.A. Ariens, T.D. Spector, and P.J. Grant The genetics of haemostasis: a twin study Lancet 357 2001 101 105
24. L. Moller, T.S. Kristensen, and H. Hollnagel Social class and cardiovascular risk factors in Danish men Scand. J. Soc. Med. 19 1991 116 126
25. P. Suadicani, H.O. Hein, and F. Gyntelberg Socio-economic status, ABO phenotypes and risk of ischaemic heart disease: an 8-years follow-up in the Copenhagen Male Study J. Cardiovasc. Risk 7 2000 277 283
26. P. Suadicani, H.O. Hein, and F. Gyntelberg Socio-economic status and ischaemic heart disease mortality Int. J. Epidemiol. 30 2001 248 255
27. A. Rosengren, L. Wilhelmsen, and L. Welin Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men BMJ 300 1990 634 638
28. M. Woodward, J. Oliphant, G. Lowe, and H. Tunstall-Pedoe Contribution of contemporaneous risk factors to social inequality in coronary heart disease and all causes mortality Prev. Med. 36 2003 561 568
29. G.M. Fuller, and Z. Zhang Transcriptional control mechanism of fibrinogen gene expression Ann. N. Y. Acad. Sci. 936 2001 469 479
30. H.C. Simpson, J.I. Mann, T.W. Meade, R. Chakrabarti, Y. Stirling, and L. Wolf Hypertriglyceridaemia and hypercoagulability Lancet ii 1983 786 789
31. J.-M. Fernandez-Real, M. Broch, and J. Vendrell Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects J. Clin. Endocrinol. Metab. 85 2000 1334 1339
32. I. Lemieux, B. Lamarche, and C. Couillard Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study Arch. Intern. Med. 161 2001 2685 2692
33. F. Green, A. Hamsten, and M. Blomback The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden Thromb. Haemost. 70 1993 915 920
34. I. Behague, O. Poirier, and V. Nicaud Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde Circulation 93 1996 440 449
35. A. Tybjaerg-Hansen, B. Agerholm-Larsen, and S.A. Humphries A common mutation (G-455→A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study J. Clin. Invest. 99 1997 3039 3049
36. M.P. de Maat, J.J. Kastelein, and J.W. Jukema -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for the acute-phase reaction pattern of fibrinogen: REGRESS group Arterioscler. Thromb. Vasc. Biol. 18 1998 265 271
37. A.R. Folsom, N. Aleksic, C. Ahn, E. Boerwinkle, and K.K. Wu Beta-fibrinogen gene -455 G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) study Ann. Epidemiol. 11 2001 166 170
38. D.J. Brull, S. Dhamrait, and R. Moulding The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise Thromb. Haemost. 87 2002 37 41
39. T.A. Lakka, and J.T. Salonen Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men J. Clin. Epidemiol. 46 1993 1119 1127
40. T. Rankinen, R. Rauramaa, and S. Vaisanen Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women Atherosclerosis 102 1993 181 186
41. J.N. Primrose, J.A. Davies, C.R. Prentice, R. Hughes, and D. Johnston Reduction in factor VII, fibrinogen, and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity Thromb. Haemost. 68 1992 396 399